Perspective Therapeutics Inc.

CATX | AMEX

Price Alert Chart Builder DCF Calculator

$2.88

-$0.09 (-3.03%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.03%

(1D)

Rating

Updated: Aug 28, 2026

20.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $327.88M

1D Range

2.81 3

52W Range

1.96 6.16

Valuation (TTM)

PE -2.08

PB 1.05

EV/EBITDA -0.90

Valuation (NTM)

Forward PE N/A

Forward PEG -0.36

Price Target $11

Cash Flow

FCF Yield -35.8%

SBC Adj. FCF Yield -38.8%

SBC Impact -8.3%

Margins

Gross Margin -419.4%

Operating Margin -30619.1%

FCF Margin -29630.1%

Growth (CAGR)

Revenue 3Y | 5Y -61.0% | -47.3%

Dil EPS 3Y | 5Y -14.1% | -42.2%

FCF 3Y | 5Y -55.6% | -54.4%

Returns

ROA -29.7%

ROE -41.6%

ROIC -34.9%

Financial Health

Net Cash

$234.51M

Current Ratio 6.61

Interest Coverage -410.60

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical produc...

Sector Healthcare

Industry Medical - Devices

Employees 165

IPO Date Nov 9, 2005

Website www.perspectivetherapeutics.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11

Upside

+281.94%

Buy (7)

Hold (1)

Sell (0)

Analyst Details ➞